Delivery Order SPE2DB20D1100-SPE2DB25FC6P9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,082.94 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack units) on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,530.11 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count package) on June 6, 2025, with completion expected by June 9, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,399.15 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 microgram/day contraceptive patches (3-count units) on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $5,940.28 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (quantity: 3 units). This competitively awarded, firm fixed-price delivery order is not set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,948.40 delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-month supply) on September 26, 2025, with completion targeted for September 29, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $34,351.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (3-unit pack). This non-set-aside competitive award represents a child delivery order executed on September 26, 2025, with an ultimate completion date of September 29, 2025. The product will be delivered to the company's Conshohocken, Pennsylvania location, serving as part of the federal medical supply chain supporting military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,428.13 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack units). This competitively awarded, non-set-aside delivery order reflects firm fixed pricing and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,670.35 on August 25, 2025, for Xulane 150-35 mcg/day contraceptive patches (quantity of 3 units). This firm fixed-price delivery order, which is not set-aside, is expected to be completed by August 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a $1,719.90 delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger prime indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,782.07 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count packages) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger relationship...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC6P9Delivery Order
The Defense Logistics Agency awarded a $1,204.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-pack). This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical supply vehicle valued through December 2026. The delivery order is scheduled for completion by June 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, leverages its DLA Troop Support Medical IDC to fulfill pharmaceutical and medical supply needs across military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates extensive capability in distributing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for contraceptive pharmaceutical products falls within the company's broader scope of providing comprehensive pharmaceutical support to sustain military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/3/25 |